Primary Job Title Founder Primary Organization 
Omega Pharmaceuticals
Location Belgium, Europe Regions European Union (EU), Europe, Middle East, and Africa (EMEA) Gender Male
Investor Type Investor Stage Number of Exits
LinkedIn View on LinkedIn
Overview
Personal Investments
Announced Date | Organization Name | Lead Investor | Funding Round | Money Raised |
|---|---|---|---|---|
 Fagron SA | Post-IPO Equity - Fagron SA | |||
 SOPHiA GENETICS | Series C - SOPHiA GENETICS |
Partner Investments
Announced Date | Organization Name | Investor Name | Lead Investor | Funding Round | Money Raised |
|---|---|---|---|---|---|
 Lizy |  Alychlo | Venture Round - Lizy | |||
Lizy | Alychlo | Series A - Lizy | |||
 Itineris | Alychlo | Venture Round - Itineris |
Exits
- SOPHiA GENETICS
SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine. 
Fagron SAFagron is a pharmaceutical company specializing in chemicals, equipment, and supplies solutions.
Omega PharmaceuticalsFounder
Related Hubs
Hub Name | CB Rank (Hub) |
|---|---|
 Investors Active in Belgium |
Recent News and Activity
Fagron SA raised from Marc Coucke and Waterland Private Equity
SOPHiA GENETICS raised from Marc Coucke and Reference Capital SA
